ArticleGynecologic oncology reports2024

A case of malignant transformation of a serous borderline ovarian tumor effectively treated with BRAF/MEK inhibitor combination.

Manrose Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.